PURPOSE: The higher prevalence rates of depression and anxiety disorders in women compared to men have been associated with sexual dimorphisms in the serotonergic system. The present positron emission tomography (PET) study investigated the influence of sex on the major inhibitory serotonergic receptor subtype, the serotonin-1A (5-HT(1A)) receptor. METHODS: Sixteen healthy women and 16 healthy men were measured using PET and the highly specific radioligand [carbonyl-(11)C]WAY-100635. Effects of age or gonadal hormones were excluded by restricting the inclusion criteria to young adults and by controlling for menstrual cycle phase. The 5-HT(1A) receptor BP(ND) was quantified using (1) the 'gold standard' manual delineation approach with ten regions of interest (ROIs) and (2) a newly developed delineation method using a PET template normalized to the Montreal Neurologic Institute space with 45 ROIs based on automated anatomical labeling. RESULTS: The 5-HT(1A) receptor BP(ND) was found equally distributed in men and women applying both the manual delineation method and the automated delineation approach. Women had lower mean BP(ND) values in every region investigated, with a borderline significant sex difference in the hypothalamus (p = 0.012, uncorrected). There was a high intersubject variability of the 5-HT(1A) receptor BP(ND) within both sexes compared to the small mean differences between men and women. CONCLUSIONS: To conclude, when measured in the follicular phase, women do not differ from men in the 5-HT(1A) receptor binding. To explain the higher prevalence of affective disorders in women, further studies are needed to evaluate the relationship between hormonal status and the 5-HT(1A) receptor expression.
PURPOSE: The higher prevalence rates of depression and anxiety disorders in women compared to men have been associated with sexual dimorphisms in the serotonergic system. The present positron emission tomography (PET) study investigated the influence of sex on the major inhibitory serotonergic receptor subtype, the serotonin-1A (5-HT(1A)) receptor. METHODS: Sixteen healthy women and 16 healthy men were measured using PET and the highly specific radioligand [carbonyl-(11)C]WAY-100635. Effects of age or gonadal hormones were excluded by restricting the inclusion criteria to young adults and by controlling for menstrual cycle phase. The 5-HT(1A) receptor BP(ND) was quantified using (1) the 'gold standard' manual delineation approach with ten regions of interest (ROIs) and (2) a newly developed delineation method using a PET template normalized to the Montreal Neurologic Institute space with 45 ROIs based on automated anatomical labeling. RESULTS: The 5-HT(1A) receptor BP(ND) was found equally distributed in men and women applying both the manual delineation method and the automated delineation approach. Women had lower mean BP(ND) values in every region investigated, with a borderline significant sex difference in the hypothalamus (p = 0.012, uncorrected). There was a high intersubject variability of the 5-HT(1A) receptor BP(ND) within both sexes compared to the small mean differences between men and women. CONCLUSIONS: To conclude, when measured in the follicular phase, women do not differ from men in the 5-HT(1A) receptor binding. To explain the higher prevalence of affective disorders in women, further studies are needed to evaluate the relationship between hormonal status and the 5-HT(1A) receptor expression.
Authors: Robert B Innis; Vincent J Cunningham; Jacques Delforge; Masahiro Fujita; Albert Gjedde; Roger N Gunn; James Holden; Sylvain Houle; Sung-Cheng Huang; Masanori Ichise; Hidehiro Iida; Hiroshi Ito; Yuichi Kimura; Robert A Koeppe; Gitte M Knudsen; Juhani Knuuti; Adriaan A Lammertsma; Marc Laruelle; Jean Logan; Ralph Paul Maguire; Mark A Mintun; Evan D Morris; Ramin Parsey; Julie C Price; Mark Slifstein; Vesna Sossi; Tetsuya Suhara; John R Votaw; Dean F Wong; Richard E Carson Journal: J Cereb Blood Flow Metab Date: 2007-05-09 Impact factor: 6.200
Authors: V Arango; M D Underwood; M Boldrini; H Tamir; S A Kassir; S Hsiung; J J Chen; J J Mann Journal: Neuropsychopharmacology Date: 2001-12 Impact factor: 7.853
Authors: Andreas Hahn; Wolfgang Wadsak; Christian Windischberger; Pia Baldinger; Anna S Höflich; Jan Losak; Lukas Nics; Cécile Philippe; Georg S Kranz; Christoph Kraus; Markus Mitterhauser; Georgios Karanikas; Siegfried Kasper; Rupert Lanzenberger Journal: Proc Natl Acad Sci U S A Date: 2012-01-30 Impact factor: 11.205
Authors: Simona Spinelli; Svetlana Chefer; Richard E Carson; Elaine Jagoda; Lixin Lang; Markus Heilig; Christina S Barr; Stephen J Suomi; J Dee Higley; Elliot A Stein Journal: Biol Psychiatry Date: 2010-02-20 Impact factor: 13.382
Authors: Eydie L Moses-Kolko; Julie C Price; Nilesh Shah; Sarah Berga; Susan M Sereika; Patrick M Fisher; Rhaven Coleman; Carl Becker; N Scott Mason; Tammy Loucks; Carolyn C Meltzer Journal: Neuropsychopharmacology Date: 2011-08-17 Impact factor: 7.853
Authors: J S Dileep Kumar; Ramin V Parsey; Suham A Kassir; Vattoly J Majo; Matthew S Milak; Jaya Prabhakaran; Norman R Simpson; Mark D Underwood; J John Mann; Victoria Arango Journal: Brain Res Date: 2013-02-27 Impact factor: 3.252
Authors: A Veronica Witte; Agnes Flöel; Patrycja Stein; Markus Savli; Leonhard-Key Mien; Wolfgang Wadsak; Christoph Spindelegger; Ulrike Moser; Martin Fink; Andreas Hahn; Markus Mitterhauser; Kurt Kletter; Siegfried Kasper; Rupert Lanzenberger Journal: Hum Brain Mapp Date: 2009-08 Impact factor: 5.038
Authors: Cynthia A Munro; Clifford I Workman; Elisse Kramer; Carol Hermann; Yilong Ma; Vijay Dhawan; Thomas Chaly; David Eidelberg; Gwenn S Smith Journal: Synapse Date: 2012-08-28 Impact factor: 2.562